Six years after the autumn of Theranos, firms are once more exploring innovation in blood testing. The medical neighborhood is reacting with cautious optimism.
MICHEL MARTIN, HOST:
Six years after the autumn of Theranos, innovators are once more venturing into blood testing. A startup in Texas is promising pace and comfort with a brand new kind of finger-prick check. Olivia Aldridge of member station KUT appeared into reactions from prospects and medical professionals.
OLIVIA ALDRIDGE, BYLINE: On a latest Friday, Jim Ross visits Lake Hills Pharmacy in Austin to have his blood drawn. At this appointment, there isn’t any lengthy, intimidating needle, no looking round for a vein.
JIM ROSS: Ah, there we go.
ALDRIDGE: As an alternative, Ross places his hand on a warming machine, and a pharmacy technician squeezes only a pea-size quantity of his blood from his fingertips.
UNIDENTIFIED PHARMACY TECHNICIAN: Now, we will use certainly one of these two fingers. Do you’ve gotten a desire?
ROSS: No.
ALDRIDGE: Forward of the appointment, Ross selected from an internet menu of 11 widespread blood assessments – measurements like ldl cholesterol, kidney operate and blood rely. And by tomorrow morning, he’ll get a textual content message with a plain-language clarification of his outcomes.
ROSS: I went to my annual bodily, and the physician made some medicine modifications. So it is simply good to have the ability to simply drop in and get a check to see if issues had been working nicely now.
ALDRIDGE: This blood testing service is known as BetterWay, and it hit the market at almost a dozen Austin pharmacies this summer season. It is obtainable by insurance coverage with a health care provider referral or as an out-of-pocket buy. It is focused at individuals like Ross, who need to monitor their well being a little bit extra carefully and who need a neater method to entry routine blood work. Eric Olson is the chief working officer of BetterWay’s mum or dad lab, Babson Diagnostics.
ERIC OLSON: It is having to take a number of buses to get to the affected person service middle that you just need to go to, or it is the inconvenience of taking break day of labor to get to a spot that is solely open weekdays and in the midst of the day.
ALDRIDGE: A veteran of the blood testing business, Olson says BetterWay’s technique breaks the mould and that pharmacy techs and every kind of suppliers – not simply blood draw specialists – could be educated to make use of it at handy places exterior the physician’s workplace.
OLSON: It is one thing that turns into simple to suit into your life and harder to only skip.
ALDRIDGE: BetterWay is certainly one of many firms angling to carve out their very own area of interest within the blood testing market utilizing small quantities of blood. However all of them have the additional burden of answering for one firm’s crimes. That firm, after all, is Theranos. Its founder, Elizabeth Holmes, is serving an 11-year sentence for fraud and conspiracy at a federal jail in Texas.
DAVID KOCH: She hoodwinked lots of people.
ALDRIDGE: That is David Koch, a professor of pathology and laboratory medication at Emory College in Atlanta.
KOCH: It is unlucky that, you realize, a number of us are skeptical as a result of Theranos did not do it the precise means.
ALDRIDGE: Theranos mentioned it might run assessments for tons of of circumstances – from HIV to most cancers – utilizing just some drops of blood on a small proprietary machine. It did not work. As an alternative, the corporate was usually diluting samples and working them by means of conventional lab tools, resulting in inaccurate outcomes. BetterWay’s strategy is totally different. It does use an on-site machine that prepares samples for testing, however the precise assessments occur again on the lab utilizing pretty conventional tools. Plus, for now, it sticks to the fundamentals, providing solely a panel of routine assessments. So are the consultants shopping for what BetterWay is promoting? Professor David Koch says it is an interesting idea, however he is nonetheless skeptical.
KOCH: We’re on this new know-how, but it surely’s started working nicely. And the way do we all know that it really works nicely? By testing it – by placing it by means of its paces.
ALDRIDGE: Koch says he must see knowledge revealed in peer-reviewed research earlier than he’ll begin to really feel assured. BetterWay does share some medical trial knowledge on its web site, and its founder, Eric Olson, says a number of submissions to medical journals are presently pending. Due to Theranos, he is aware of incomes the medical neighborhood’s belief goes to be powerful, however he does additionally give Theranos some credit score for making an attempt to shake up a static business.
OLSON: For as a lot of a fraud and a catastrophe because it was for public belief, it was inspiring in that it opened minds to the potential that blood testing could possibly be totally different from how it’s in the present day.
ALDRIDGE: And as BetterWay and its friends start to ramp up, you possibly can guess that scientists and buyers will maintain an in depth eye on what’s promised and delivered.
For NPR Information, I am Olivia Aldridge in Austin.
Copyright © 2024 NPR. All rights reserved. Go to our web site phrases of use and permissions pages at www.npr.org for additional data.
NPR transcripts are created on a rush deadline by an NPR contractor. This textual content might not be in its last type and could also be up to date or revised sooner or later. Accuracy and availability could fluctuate. The authoritative document of NPR’s programming is the audio document.